Login
Toggle navigation
Videos
Categories
Trending
Shifting from Operator to Investor|Eva Alonso,Investor,Ribbit Capital
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Prior to Ribbit Capital, Eva served as an investor at Goldman Sachs
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Bunker Hill Mine: Restarting an Iconic U.S. Asset with Strategic Financing
00:10:00
Sandstorm Gold President and CEO Nolan Watson discusses company updates, while Remark Holdings, Inc. (NASDAQ: MARK) shares market insights.
00:10:00
Stefan Stewart Discusses QC Copper's High-Grade Discovery and Industry Challenges
00:10:00
Founder turned investor now spending the majority of their time to seek the opportunities|Brian Ma,Founder and Managing Partner, Iterative VC
00:10:00
Transform Your Business with Liberty International Partners' Digital Solutions
00:10:00
Deepinder Goyal, CEO of Zomato, Confident of 10x Profit in Five Years | Deepinder Goyal, CEO , Zomato Ltd.
00:00:00
ollagen Solutions 'well on track' with plans for CE Mark and first surgery - Jamal Rushdy, Chief Executive Office, Collagen Solutions
00:10:00
Cavidan Karaca on Company Activities, Investments, and Public Offering Insights | Cavidan Karaca, CEO , Kimteks Poliuretan Sanayi ve Ticaret A.Ş.
00:10:00
Navigating Raw Material Challenges: Tire Industry Demand and Growth Outlook for 2023|Mr. Suresh Sodani,Managing Director,Century Enka Ltd
00:10:00
Immigrant Entrepreneur Life Science Business Awardee|Avak Kahvejian,General Partner,Flagship Pioneering
00:10:00
Gold Investment and the Al Fariq Project: Insights from Chuck Fipke and Chad Dolansky
00:10:00
The Power of Annual Reset: Protect Your Green Money | Dave Gner, Founder, Legacy Financial Strategies, Inc.